COMMUNIQUÉS West-GlobeNewswire

TearLab Corporation Reports Fourth Quarter and Full Year 2017 Financial Results
02/03/2018
SAN DIEGO, March 02, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended [...]
Melinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care Conference
02/03/2018
NEW HAVEN, Conn., March 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage pharmaceutical company developing and commercializing novel antibiotics to treat serious bacterial [...]
Cannabis Wheaton Income Corp. Announces Filing of Amended and Restated Final Base Shelf Prospectus
02/03/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis [...]
BIONOVELUS C.I.O.DEPARTURE
02/03/2018
FOR IMMEDIATE RELEASE / Phoenix, March 02, 2018 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (ONOV), whose CR-10® Biofungicide is a non-toxic solution for safe and effective pre- and post-harvest applications, is announcing [...]
Stanley A. Plotkin, M.D. Steps Down from Board of Dynavax Technologies
02/03/2018
BERKELEY, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (“Dynavax”) (NASDAQ: DVAX ) announced today that Stanley A. Plotkin, M.D. has indicated his intention to step down from the Board of [...]
ChromaDex Sets Fourth Quarter and Full Year 2017 Conference Call for Thursday, March 8, 2018 at 4:30 p.m. ET
02/03/2018
IRVINE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age, will hold a [...]
Orion Corporation: Managers' transactions - Olli Huotari
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Olli Huotari Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers' transactions - Timo Lappalainen
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation [...]
Orion Corporation: Managers' transactions - Virve Laitinen
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]
Orion Corporation: Managers' transactions - Satu Ahomäki
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers' transactions - Markku Huhta-Koivisto
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Markku Huhta-Koivisto Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Jari Karlson
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Jari Karlson Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers' transactions - Christer Nordstedt
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Christer Nordstedt Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Liisa Hurme
02/03/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 2 nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
Oasmia Pharmaceutical AB (publ)
02/03/2018
Interim report for the period May 2017 – January 2018 Commercial focus and lower cost base THIRD QUARTER November 1, 2017 – January 31, 2018 Consolidated net sales amounted to TSEK 656 compared to TSEK 36 in the third [...]
Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2017
02/03/2018
Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2017 Clinical development progressed as planned Highlights in January-December 2017: Phase 1 clinical study of Herantis Pharma ("Herantis") [...]
Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients
02/03/2018
LONDON, March 02, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
NeuroSearch A/S – Annual General Meeting 2018
02/03/2018
Announcement no. 3-18 Page 1 of 1 Announcement 2 March 2018 NeuroSearch A/S (NEUR) will conduct the company's Annual General Meeting on Monday, 30 April 2018. Shareholders who wish to submit motions for the Annual [...]
ESPERITE (ESP) : L1 Capital subscribes to the 16th tranche of investment today
02/03/2018
Amsterdam, The Netherlands - 2 March 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 16 th Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]

Pages